Form 20-F TAKEDA PHARMACEUTICAL For: Mar 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260617/AALZ922CZ22QV2Z2222B2CZG2DSSZZ225C82
Filed on: June 17, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEJM publishes Takeda's phase 3 data on narcolepsy drug oveporexton
- Andrew Grosso & Associates Announces Settlement of Whistleblower Lawsuit Against the Sanmina Corporation and SCI Technology, Inc.
- Hub Group Declares Quarterly Dividend
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
